| Ytd | 30.56% | |
| 1y | 48.73% |
| Open | 2.34 | Prev Close | 2.36 | Low | 2.31 | High | 2.37 | Mkt Cap | 190.15M |
| Vol | 85.04K | Avg Vol | 724.14K | EPS | 0.18 | P/E | 12.97 | Forward P/E | 2.79 |
| Beta | N/A | Short Ratio | 22.71 | Inst. Own | 5.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.15 | 200-d Avg | 2.22 | 1yr Est | 14.00 |
PLX News
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call Transcript
Company to host conference call and webcast today at 8:00 a.m. EDT Elfabrio commercial execution con
Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, May 6, 2026 /PRNewswir
Protalix BioTherapeutics reported weaker FY25 results but issued robust FY26 revenue guidance of $78
American and European households may be growing wealthier at a similar pace, but the composition of
Tesla Inc (NASDAQ:TSLA) CEO Elon Musk on Thursday shared an update on the company’s semiconductor pl
Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call Transcript
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined
Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) appr
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined
Shares in Pennon Group PLC (LSE:PNN, OTC:PEGRY) rose 3.4% to 553.5p on Tueaday morning despite the o
AIM modelling company raises £450,000 at a steep discount, betting that investment in growth will ju
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) announced that the European Commission has appro
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) announced that the European Commission has appro
The US Justice Department has reportedly reached a settlement with Ticketmaster and its parent compa
This press release is intended for US audiences for transparency relative to global news for the Fab
Protalix BioTherapeutics (NYSE: PLX - Get Free Report) and JATT Acquisition (NYSE: JATT - Get Free R
Oral presentation provides additional scientific rationale on Krabbe disease, one of four LSDs in th
Protalix Bio Therapeutics (PLX) received a positive CHMP opinion for Elfabrio's every-four-weeks dos
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) said on Friday that the European Medicines Agenc
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings